NCT00003361 2013-06-26Decitabine in Treating Patients With Myelodysplastic SyndromeNational Cancer Institute (NCI)Phase 2 Completed75 enrolled
NCT00002980 2013-02-15Decitabine in Treating Patients With Melanoma or Other Advanced CancerNational Cancer Institute (NCI)Phase 1 Completed
NCT00114257 2013-02-11Decitabine and FR901228 in Treating Patients With Relapsed or Refractory Leukemia, Myelodysplastic Syndromes, or Myeloproliferative DisordersNational Cancer Institute (NCI)Phase 1 Completed36 enrolled
NCT00043134 2010-04-13Low-Dose Decitabine Compared With Standard Supportive Care in Treating Older Patients With Myelodysplastic SyndromeNational Cancer Institute (NCI)Phase 3 Unknown220 enrolled